@article{AOI4682,
author = {Paul O. Lewis and Kelly L. Covert and David B. Cluck},
title = {Cefazolin or nafcillin? —a commentary on the optimal treatment of methicillin-susceptible Staphylococcus aureus bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins},
journal = {Annals of Infection},
volume = {2},
number = {0},
year = {2018},
keywords = {},
abstract = {Staphylococcus aureus bacteremia represents significant burden on the healthcare system with early mortality rates as high as 60% and more recent studies suggesting mortality rates of 10–30% (1,2). While methicillin-resistant Staphylococcus aureus (MRSA) has garnered much of the attention due to higher mortality rates and treatment difficulties, the optimal treatment of methicillin-susceptible Staphylococcus aureus (MSSA) is still in question (1).},
issn = {2616-2709}, url = {https://aoi.amegroups.org/article/view/4682}
}